The niche under siege: novel targets for metastasis therapy
about
Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionBisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidenceAltered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell-Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth.
P2860
The niche under siege: novel targets for metastasis therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The niche under siege: novel targets for metastasis therapy
@ast
The niche under siege: novel targets for metastasis therapy
@en
The niche under siege: novel targets for metastasis therapy
@nl
type
label
The niche under siege: novel targets for metastasis therapy
@ast
The niche under siege: novel targets for metastasis therapy
@en
The niche under siege: novel targets for metastasis therapy
@nl
prefLabel
The niche under siege: novel targets for metastasis therapy
@ast
The niche under siege: novel targets for metastasis therapy
@en
The niche under siege: novel targets for metastasis therapy
@nl
P2860
P356
P1476
The niche under siege: novel targets for metastasis therapy
@en
P2093
A. Santamaria-Martínez
J. Huelsken
P2860
P304
P356
10.1111/JOIM.12024
P407
P577
2013-08-01T00:00:00Z